Related Experiment Video
Updated: May 15, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
High-throughput virtual screening of phloroglucinol derivatives against HIV-reverse transcriptase
Vilas Belekar1, Anup Shah, Prabha Garg
1Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Sect-67, SAS Nagar, 160062 Punjab, India.
Molecular Diversity
|January 23, 2013
Summary
This study screened phloroglucinol compounds for activity against HIV reverse transcriptase (HIV-RTase). Researchers identified 37 derivatives with strong binding affinity, suggesting potential for new anti-HIV drug development.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Computational Biology
Background:
- Therapeutic agents can have off-target effects, necessitating identification of molecules targeting multiple proteins.
- Phloroglucinols possess diverse biological activities, including antimicrobial and antiviral properties.
- Developing multi-targeted drugs can enhance efficacy and reduce costs.
Purpose of the Study:
- To investigate the potential of phloroglucinol derivatives as inhibitors of HIV reverse transcriptase (HIV-RTase).
- To identify novel anti-HIV therapeutic agents through off-target screening of existing chemical libraries.
Main Methods:
- A library of phloroglucinol derivatives was screened using toxicity and ADME (Absorption, Distribution, Metabolism, and Excretion) predictions.
- Viable compounds underwent docking analysis against the HIV-RTase enzyme.
- Binding interactions, including hydrogen bonds and π–π stacking, were analyzed.
Main Results:
- 37 phloroglucinol compounds demonstrated significant binding affinity to HIV-RTase.
- Key interactions included hydrogen bonds with Lys101, Lys103, Val106, and Leu234, and π–π stacking with Tyr318.
- These compounds exhibit diverse pharmacological profiles.
Conclusions:
- Phloroglucinol derivatives show promise as potential anti-HIV agents targeting HIV-RTase.
- Drug repurposing of phloroglucinols could lead to cost-effective therapeutic strategies.
- Further research is warranted to explore these compounds as lead candidates for HIV treatment.
